After 3 months of treatment, clinicians and patients need to decide whether to continue anticoagulant therapy long-term, which is informed by bleeding risk; to date, we have not had a good way to esti...

Predicting recurrent venous thromboembolism (rVTE) risk during and following anticoagulation is complex. Current models do not adapt to changing patient conditions, fail to account for the direct impa...

The Hybrid subCellular Protein Localiser (HCPL) improves single-cell classification for protein localization, allowing for large-scale data annotation through deep-learning architecture.

The Hybrid subCellular Protein Localiser (HCPL) improves ...